COO Stock Analysis: Buy, Sell, or Hold?
COO - The Cooper Companies, Inc. Common Stock
$65.42
-0.49 (-0.74%)
▼
5d:
-3.62%
30d:
+5.94%
90d:
-6.49%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jun 04, 2026
0d
Get Alerted When COO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: COO appears deeply undervalued. Market expects -4.6% annual earnings decline despite 27% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: COO appears deeply undervalued. Market expects -4.6% annual earnings decline despite 27% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$100.92
Based on 6.0% avg growth
INTRINSIC VALUE TODAY
$62.66
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: COO is currently trading at $65.42, which is considered slightly high relative to its 30-day fair value range of $60.52 to $66.71. From a valuation perspective, the stock is trading at a discount (Forward PE: 13.1) compared to its historical average (15.1). Remarkably, the market is currently pricing in an annual earnings decline of 4.6% over the next few years. This pessimistic expectation contrasts with the company's recent 26.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, COO is in a strong downtrend. The price is currently testing key support at $64.94. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: COO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $80.57 (+23.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, COO is in a strong downtrend. The price is currently testing key support at $64.94. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: COO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $80.57 (+23.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$60.52 -
$66.71
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.2% below Wall St target ($80.57)
Trading Range Analysis
30-Day Trading Range
$60.52 -
$66.71
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$64.94
Resistance Level
$69.00
Current Trend
Strong Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.09
Wall Street Target
$80.57
(+23.2%)
Revenue Growth (YoY)
7.9%
Earnings Growth (YoY)
26.9%
Profit Margin
5.6%
Valuation Discount vs History
-4.6% cheaper
PE vs Historical
13.1 vs 15.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.6%
(market-implied from PE analysis)
1-Year Target
$62.41
(-5%)
2-Year Target
$59.54
(-9%)
3-Year Target
$56.80
(-13%)
3-Yr Target (if PE normalizes)
(PE: 13→15)
$65.51
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 8.0%)
$136.95
(+109%)
Base:
(SPY PE: 13.1, Growth: 8.0%)
$82.33
(+26%)
Bear:
(PE: 11.1, Growth: 8.0%)
$69.98
(+7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (14x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Forward PE: 14.10 | Forward EPS (Implied): $4.64
Bull Case
$78.99
(+21%)
Analyst growth 15.0%, PE expands to 14.8
Base Case
$65.42
(0%)
Market implied 0.0%, PE stable at 14.1
Bear Case
$50.05
(-24%)
Severe decline -15.0%, PE contracts to 12.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.1 to 15.1
Stabilization Target:
$75.45
(+15.3%)
PE Expansion Potential:
+15.3%
Share & Embed Analysis
Last updated: June 23, 2026 8:37 AM ET
Data refreshes hourly during market hours. Next update: 9:37 AM
Data refreshes hourly during market hours. Next update: 9:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 55 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 55 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 64 BUY |
|
RMD
ResMed Inc |
BUY
19 analysts |
$262 | 62 BUY |
Advanced COO Option Strategies
Professional options setups generated by AI based on today's COO price and gamma walls.
